cyc 202 has been researched along with hyperoside in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (hyperoside) | Trials (hyperoside) | Recent Studies (post-2010) (hyperoside) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 394 | 0 | 271 |
| Protein | Taxonomy | cyc 202 (IC50) | hyperoside (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 1.2 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 3 | |
| 2-5A-dependent ribonuclease | Homo sapiens (human) | 1.4325 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, NI; Cho, JG; Jeon, YJ; Kim, GS; Lee, DY; Natarajan, S; Park, JH; Shrestha, S; Yang, DC; Yeon, SW | 1 |
1 other study(ies) available for cyc 202 and hyperoside
| Article | Year |
|---|---|
Potential neuroprotective flavonoid-based inhibitors of CDK5/p25 from Rhus parviflora.
Topics: Cyclin-Dependent Kinase 5; Flavonoids; Humans; Models, Molecular; Molecular Structure; Nerve Tissue Proteins; Neuroprotective Agents; Rhus | 2013 |